Comment on Sanfélix-Genovés et al.: Prevalence of osteoporotic fracture risk factors and antiosteoporotic treatments in the Valencia region, Spain. The baseline characteristics of the ESOSVAL cohort.
J D
JD
Pedrera-Zamorano
J M
JM
Lavado-Garcia
J M
JM
Moran
D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D058866:Osteoporotic Fractures / Q000453:epidemiology* / Q000209:etiology*
D050071:Bone Density Conservation Agents